Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of topical ruxolitinib phosphate in adults with atopic dermatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ruxolitinib phosphate cream (ruxolitinib phosphate)

Snippet

Sponsor: Incyte Corporation | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2021-04-09